Oculis Holding Ag's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Oculis Holding Ag's ROI in the fourth quarter of 2025?
Oculis Holding Ag recorded a cumulative net loss of $-150 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -62.45%.

Within the Healthcare sector 533 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 0 to 3928.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Investment Change TTM	186.71 %	115.12 %	56.7 %	18.62 %	-25.95 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	261	251	199	251	84
Return On Investment (TTM)	-62.45 %	-65.32 %	-82.98 %	-95.89 %	-143.64 %
OCS's Overall Ranking	# 3928	# 0	#	#	#
Seq. Investment Change TTM	22.54 %	27.04 %	22.94 %	49.8 %	-8.06 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-150	-128	-128	-120	-120

OCS Company Profile >> Back to OCS Roi Comparisons >> See Annual OCS Return On Investment

Return On Investment OCS's Ranking
Within:	No.
Industry	# 222
Sector	# 534
Overall	# 3928

Return On Investment Statistics
High	Average	Low
-49.67 %	-102.53 %	-154.54 %
(Dec 31 2025)		(Dec 31 2022)

Financial Statements
Oculis Holding Ag's IV. Quarter Investments	$ 261 Millions	OCS's Balance sheet
Oculis Holding Ag's IV. Quarter Income	$ -119 Millions	Quarterly OCS's Income Statement
OCS's Income by Division		See OCS's Income by Division

OCS Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022
Total Investments in Millions	250	84	113	17	0
Y / Y Investment Growth	199.08 %	-26 %	565.34 %	-	-
Net Income in Millions	-119	-97	-99	-41	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-47.74 %	-116.47 %	-87.48 %	-238.67 %	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
OCS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for OCS's Competitors
Subscribers only: Roi for Oculis Holding Ag's Suppliers
Subscribers only: Return On Investment for OCS's Customers

Other Ratios
OCS's Roa	OCS's Inventory Turnover Ratio	OCS's Growth Rates	OCS's Dividend Statistics
	OCS's Profitability Ratios	OCS's Asset Turnover Ratio	OCS's Dividend Growth
OCS's Roe	OCS's Valuation Ratios	OCS's Financial Strength Ratios	OCS's Dividend Payout Ratio

Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector

ROI

Date modified: 2026-09-18T13:11:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.